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No data exist on the ability of thiolation domains from fungal non-ribosomal peptide synthetases to undergo
4′-phosphopantetheinylation, using either biotinylated or fluorescently labeled coenzyme A analogues, mediated
by 4′-phosphopantetheinyl transferases (PPTase). Yet, this is a key requirement to confirm the amino acid
recognition function, and coding potential, of either non-ribosomal peptide synthetases or recombinantly expressed
regions of these enzymes (e.g., didomains or modules). Moreover, determination of 4′-phosphopantetheinylation
activity remains cumbersome. Here, we demonstrate that a recombinant fungal PPTase catalyzes the solution-
phase transfer of either biotin- or fluorescein-labeled 4′-phosphopantetheine region of coenzyme A to a fungal
thiolation domain, which is either part of a non-ribosomal peptide synthetase didomain (72 kDa), derived from
Aspergillus fumigatus, or fused to a non-native protein (glutathione s-transferase). Significantly, we demonstrate
that this reaction can unexpectedly occur when the target protein (4.4 pmol) is immobilized on a solid surface.
These findings (i) confirm that thiolation domains of fungal origin, in native or non-native configuration, can
accept modified 4′-phosphopantetheine residues via PPTase-mediated labeling and (ii) illustrate a novel, high-
throughput method to determine PPTase activity.
INTRODUCTION
Phosphopantetheinyl transferases (PPTase) catalyze the trans-
fer of 4′-phosphopantetheine from coenzyme A (CoA) to the
carrier domain of a range of enzymes involved in non-ribosomal
peptide, polyketide, and fatty acid biosynthesis (1). Non-
ribosomal peptide (NRP) synthetases are produced in the
inactive (apo-) form and are post-translationally modified by
PPTase to the active (holo-) form by the covalent attachment
of CoA-derived 4′-phosphopantetheine to a reactive serine
residue in thiolation (T) domains (also referred to as peptidyl
carrier protein (PCP)) within the NRP synthetase (2). Initial
strategies for assaying 4′-phosphopantetheinylation involved the
use of [3H]-pantetheine CoA and liquid scintillation counting
(3), HPLC separation, and analysis of purified proteins (4). More
recently, the application of protein mass spectrometry for the
determination of apoenzyme 4′-phosphopantetheinylation has
been reported (2, 5). These conventional methods for assaying
PPTase activity, however, can be costly and cumbersome and
significantly limit high-throughput operations (6).
An elegant method of covalently labeling T/PCP domains of
NRP synthetases, using biotinylated or fluorescently labeled
CoA, and a recombinant Bacillus subtilis encoded PPTase, Sfp,
in PPTase-mediated reactions has been described (6). These
authors used Sfp to catalyze modification of carrier proteins
with a single fluorescent or affinity reporter, providing a sensitive
means of protein visualization, Western blot identification, and
affinity purification. This labeling technique also has utility in
the identification of carrier protein domains from lysates of
native cultures, as a proportion of carrier proteins in the lysate
may be present in an unmodified inactive state. Application of
the technique to the 6-deoxyerythronolide B synthase (DEBS)
pathway from Saccharapolyspora erythraea resulted in the
identification of a 150 kDa protein indicative of native DEBS
(6).
The ability of PPTases to post-translationally modify carrier
proteins using low molecular mass chemical labels represents
a novel and efficient tool for protein labeling and has significant
implications in biomolecular research. This approach has been
adapted to fluorescence imaging of cellular events involving
transferrin-mediated iron uptake (7) where the transferrin
receptor 1 (TfR1) was fused to a PCP, and the resultant TfR1-
PCP fusion specifically labeled with a fluorophore via the action
of Sfp. In an independent study, an 11-residue peptide, DSLE-
FIASKLA, predicted to be a suitable target for modification by
the B. subtilis Sfp was fused to the C- and N-termini of target
protein and subsequently labeled with a biotin tag by the PPTase
(8). The majority of reporter labeling of carrier proteins by
promiscuous PPTases have been limited to in Vitro and cell
surface protein labeling (9-11). A chemoenzymatic route to
protein modification in ViVo using a fluorescent marker has also
been reported (12). This mechanism centered on the ability of
native enzymes present in E. coli, CoAA, and CoAD and CoAE
to sequentially modify a fluorescent pantetheine analogue to
result in a fluorescently labeled CoA analogue. Coexpression
of the carrier protein VibB and the PPTase Sfp in the presence
of the fluorescent pantetheine analogue resulted in the fluores-
cent modification of the VibB carrier protein in ViVo.
The PPTase-mediated modification of bacterial pyochelin
NRP synthetase carrier proteins PchE and PchF using fluorescein
(Fl)-CoA analogues has also been reported (13). These in Vitro
4′-phosphopantetheinylation assays used 2 µM B. subtilis Sfp,
300 µM Fl-CoA, and PchE/ PchF carrier proteins at concentra-
tions of 10 and 21 µM, respectively. The detection of the
modified carrier proteins in this study was enabled by Fourier
transform mass spectrometry whereby mass shifts were observed
for reporter labeled peptides.
In Vitro 4′-phosphopantetheinylation assays have been used
to investigate the effect of inhibitors on PPTase activity (14).
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Here, the efficacy of novel anthranilic acid inhibitors of the B.
subtilis acyl carrier protein synthase (AcpS), which catalyzes
the transfer of 4′-phosphopantetheinyl group from CoA onto a
conserved serine residue present on an E. coli acyl carrier protein
(ACP), was assessed and found to exhibit IC50 (µM) values of
0.82-32.3. The effect of these inhibitors was determined in a
solution phase assay format, which involved incubation of the
AcpS (a PPTase) in the presence of a GST-linked ACP carrier
protein and a biotin-CoA reporter analogue at room temperature.
Detection of the biotin-labeled ACP was achieved by an
overnight incubation with streptavidin-allophycocyanin con-
jugate followed by time-resolved fluorescence detection.
A PPTase from Aspergillus fumigatus has recently been
expressed in, and purified from, recombinant baculovirus
infected Spodoptera frugiperda9 (Sf9) insect cell supernatants.
Subsequent mass spectrometric detection of a 4′-phosphopan-
tetheinylated peptide confirmed that this secreted PPTase post-
translationally modified a recombinant NRP synthetase T
domain from A. fumigatus Pes1 in the presence of CoA (2). To
date, the compatibility of this fungal PPTase has not been
demonstrated with modified CoA derivatives; moreover, limited
amounts of the secreted PPTase has hindered complete enzyme
characterization, and the assay systems for detection of 4′-
phosphopantetheinylation are cumbersome and time-consuming.
EXPERIMENTAL METHODS
Bioinformatic Analysis. Preliminary sequence data were
obtained from The Institute for Genomic Research Website at
http://www.tigr.org. The unannotated genome of Aspergillus
fumigatus was initially investigated to identify open reading
frames corresponding to novel NRP synthetases. One open
reading frame, which encoded a putative NRP, was identified
and was subsequently termed pes3 (Figure 1).
Fungal DNA Isolation and PCR Amplification. A. fumi-
gatus strain ATCC 26933 was grown (250 mL cultures) at 37
°C in minimal essential medium (MEM) (5% (v/v) containing
fetal calf serum (FCS)) for 2 days. Genomic DNA was isolated
by crushing fungal mycelia in liquid N2 followed by phenol/
chloroform extraction, washing with 70% (v/v) ethanol and final
DNA resuspension in 10 mM Tris-HCl, 1 mM EDTA pH 8.0
(200 µL). PCR was carried out using AccuTaq LA polymerase
(Sigma) using a total of 5 ng of genomic DNA per PCR reaction.
PCR reactions also included 10× AccuTaq reaction buffer, 0.25
µM of each dNTP, 1.0 µM forward and reverse primer (Table
1) in a total volume of 20 µL. PCR reactions comprised an
initial step of 60 s denaturation at 95 °C, followed by 30 cycles
consisting of 60 s at 95 °C, 30 s at 55 °C, 90 s at 72 °C, and
finally 360 s at 72 °C. Amplicons were analyzed by agarose
gel electrophoresis and visualized using an Eagle-Eye II digital
still video system (Stratagene, CA, USA). DNA sequence
analysis was carried out on a commercial basis by MWG
Biotech (Germany).
Cloning and Expression of the Nonribosomal Peptide
Synthetase Gene Fragment, pes3AT. The pes3AT amplicon,
which is derived from the 5′ end of the entire pes3 gene (Figure
1), was initially cloned into the TOPO cloning vector and
subsequently cloned into pProEx expression vectors (Invitrogen)
according to the manufacturer’s instructions. pProEx:pes3AT, the
expression vector containing the region encoding the initial AT
didomain of pes3 (A. fumigatus pes3AT) (Figure 1), was
transformed into E. coli according to the manufacturer’s
guidelines (Invitrogen). Protein expression was induced by the
addition of isopropyl -D-1-thiogalactopyranoside (IPTG; 0.6
mM final concentration) and monitored by SDS-PAGE, Western
blot analysis using monoclonal antibody reactivity against a His6
fusion peptide, and MALDI-ToF mass spectrometry (15).
Recombinant Pes3AT Purification and Refolding. Recom-
binant Pes3AT was purified under denaturing conditions using
Ni-NTA metal-chelate affinity chromatography in the presence
of 6 M guanidine-HCl. Purified recombinant Pes3AT (250 µg/
mL) in 50 mM sodium carbonate pH 9.4 containing 6 M
guanidine-HCL was serially dialyzed into 50 mM sodium
carbonate pH 9.4 containing 8 M urea, then 4 M urea, followed
by dialysis into 50 mM sodium carbonate buffer pH 9.4 to
facilitate solubilization.
Generation of Recombinant Fusion Protein (T-GstB)
Containing the Pes3AT Derived Thiolation Domain. The
region encoding the thiolation (PCP) domain from pes3AT was
fused to A. fumigatus glutathione s-transferase B (gstB (16)) in
order to assess the utility of the domain for non-native protein
labeling (Figure 1). PCR cloning primers incorporated EcoRI
and HindIII restriction sites to facilitate PCR amplification and
directional subcloning of the T region (Table 1). This amplicon
(196 bp) was subsequently digested with EcoRI and HindIII
and ligated to the pProEx-gstB expression vector (16), which
had also been digested with EcoRI and HindIII. The expression
vector containing T-GstB was then transformed into E. coli
DH5R according to refs 16 and 17. Protein expression was
induced by the addition of IPTG (0.6 mM final concentration)
and monitored by SDS-PAGE and Western blot analysis.
Purification of the T-GstB fusion protein was carried out as
previously described (2).
PPTase Extraction from Infected (Sf9) Insect Cells. Sf9
insect cells (5 × 107), previously infected with recombinant
baculovirus encoding PPTase (2), were resuspended in Ppant
buffer (5 mL; 75 mM Tris-HCl, 5 mM dithiothreitol (DTT),
and 10 mM MgCl2 pH 8.0) and sonicated (Bandelin Sonopuls,
Progen Scientific Ltd., UK) for 3 × 5 s at a maximum power
for 5 min with 30 s second intervals on ice. The resultant cell
lysates were centrifuged at 10 000g for 10 min at 4 °C. The
supernatants were removed and analyzed for the presence of
PPTase by Western blot analysis. The concentration of protein
present in the cell lysate supernatants was determined by
Figure 1. Diagrammatic representation of (A) Pes3 domain architecture,
and (B) thiolation (T)-GstB fusion protein. The first adenylation domain
and thiolation domain from module 1 of Pes3 (Pes3AT) were selected
for recombinant protein production. Wavy lines shown in A indicate
covalently tethered phosphopantetheine moieties to T domains (shaded).
The T-GstB fusion protein is also illustrated showing the Pes3 thiolation
domain (T) fused to the GstB protein. The N- and C-termini of both
proteins are indicated.
Table 1. Oligonucleotide Primers Designed for Directional Cloning
of pes3AT and T/PCP Region Sequences into the pProEx-GstB
Expression Vector
gene (F/R) primer sequences (5′-3′)
amplicon
(bp)
pes3AT F GAGACTCGAGACATACGCCGAACTGGAA 1800
pes3AT R GAGAAAGCTTAGTGATCGAGGAACGCAA
T/PCP F GAGAGGATCCCATGGAACGCCGGTTGCGAG 196
T/PCP R GAGAGAATTCTGCGAGCTCTGTGATGGA
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Bradford analysis and the supernatants divided into 0.5 mL
aliquots and stored at -20 °C for further use.
For purification of intracellular PPTase, infected Sf9 insect
cells (5 × 107) were resuspended in lysis buffer (5 mL; 50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole pH 8.0) containing
0.05% (w/v) sodium deoxycholate and sonicated (Bandelin
Sonopuls, Progen Scientific Ltd., UK) for 3× 5 s at a maximum
power for 5 min with 30 s intervals on ice and the resultant
lysates centrifuged at 10 000g for 10 min at 4 °C. Purification
proceeded under native conditions using Ni-NTA metal-chelate
affinity chromatography. Optimal protein yields were obtained
using an optimized batch purification approach which entailed
the incubation of the PPTase lysate to the Ni-NTA resin for
2 h with gentle inversion at 4 °C. Subsequently, the protein/
resin complex was packed into a column to facilitate washing
and elution steps. Purified PPTase was eluted with 250 mM
imidazole and subsequently dialyzed into Ppant buffer.
Coenzyme A Analogue Synthesis and Solution Phase
PPTase Activity Analysis. Coenzyme A (CoA) was covalently
labeled through an available sulfhydral group by reaction with
either maleimido-dPEG4-biotin (MB) (Quanta BioDesign Ltd.,
Ohio, USA) or 5′-iodoacetamidofluorescein (Sigma-Aldrich)
according to ref 6 with modifications (Supporting Information).
All reactions were allowed to proceed on ice for 30 min,
followed by 10 min incubation at room temperature, and
terminated by addition of 1 M DTT (1 µL). 4′-Phosphopan-
tetheinylation reactions using PPTase and recombinant Pes3AT
were carried out as follows: Reaction mixtures for the in Vitro
4′-phosphopantetheinylation assay contained Pes3AT (4.4 µM),
PPTase (0.08 µM), biotin-CoA (8.4 µM) in 75 mM Tris-HCL,
5 mM DTT, and 10 mM MgCl2, pH 8.0 (final volume: 100
µL). Reaction mixtures were incubated at 37 °C for 1 h. After
incubation, reactions were terminated by the addition of 10%
(w/v) trichloroacetic acid (900 µL) and centrifuged at 10 000g
for 10 min. Pellets were resuspended in 1 M Tris-HCl pH 8.0
and analyzed by SDS-PAGE and Western blot analysis, using
direct probing with streptavidin-horseradish peroxidase (HRP)
(1/500) and ECL chemiluminescent substrate (Pierce Biotech-
nology), to visualize biotinylated Pes3AT. Fluorescence detection
was also undertaken by directly scanning SDS-PAGE gels, when
fluorescein-CoA (Fl-CoA) (6) was employed instead of biotin-
CoA (6), using a Typhoon variable mode imager (GE Health-
care) at excitation and emission wavelength at 488 and 520 nm,
respectively. Scanned gels were subsequently stained with
Coomassie Brilliant Blue R. Alternatively, reaction mixtures
were directly added to Nunc Maxisorb microwells (1 h), washed
using phosphate buffered saline 0.05% (w/v) Tween-20 (PBST),
and fluorescence detected using a plate reader (Bio-Tech,
Synergy HT) with excitation and emission values of 490 and
520 nm, respectively.
Microwell Coating with Recombinant Pes3AT, T-GstB,
or GstB for Use in Solid Phase 4′-Phosphopantetheinyla-
tion Assays. Microtiter plates were coated with purified
recombinant Pes3AT (2 µg/mL) diluted in 50 mM sodium
carbonate buffer pH 9.6 containing 0.01% (w/v) sodium dodecyl
sulfate (100 µL/well). Plates were incubated at 37 °C for 2 h
and washed twice with PBST (200 µL). Blocking solution (1%
(w/v) bovine serum albumin and 10% (w/v) sucrose in 50 mM
sodium carbonate buffer pH 9.6; 200 µL/well) was applied to
the wells and stored at 4 °C overnight. Blocking solution was
decanted from plates, and any residual solution was removed
by tapping the plate upside down onto adsorbent paper and
transferring the plate to a 37 °C incubator for 1 h prior to use.
Microwells were also individually coated with the T-GstB and
GstB, respectively (5 µg/mL), for subsequent use in the solid
phase 4′-phosphopantetheinylation assays. Microwell coating
of T-GstB and GstB and subsequent 4′-phosphopantetheinylation
assays were carried out as described for Pes3AT.
Solid Phase 4′-Phosphopantetheinylation Using Biotin-
CoA. Reactants were prepared in triplicate in 1.5 mL microfuge
tubes as outlined in Table 2. Aliquots (100 µL) of each sample
were placed in wells of 96-well plates (Nunc Maxisorb) which
had been previously coated with Pes3AT (2 µg/mL). Plates were
incubated for 1 h at room temperature to facilitate enzymatic
reaction. Plates were then washed twice with PBST. Strepta-
vidin-HRP (1/2000 dilution; 100 µL/ well) was added and
plates incubated at 37 °C for 1 h. Plates were washed 4 times
with PBST. Excess liquid was removed from the wells by
tapping the plate out on adsorbent paper. Substrate (3,3′,5,5′-
tetramethylbenzidine; TMB; 100 µL/well) was applied to the
wells and left to develop for 10 min at room temperature. To
terminate the reaction, 1 N H2SO4 (100 µL) was added to the
wells, and the absorbance values read at 450/630 nm using a
plate reader (Bio-Tech, Synergy HT).
Solid Phase 4′-Phosphopantetheinylation Using Fl-CoA.
Reactants were prepared in triplicate in 1.5 mL microfuge tubes
as outlined in Table 3. Aliquots (100 µL) of each sample were
placed in wells of black 96-well plates (Nunc Maxisorb) which
had been previously coated with Pes3AT (2 µg/mL). Plates were
incubated for 1 h at room temperature in the dark while the
enzymatic reaction occurred. Plates were then washed twice with
PBST and excess liquid removed by tapping the plates on
adsorbent paper. Fluorescence was detected using a plate reader
(Bio-Tech, Synergy HT) with excitation and emission values
of 490 and 520 nm, respectively.
PPTase Characterization Using Solid Phase 4′-Phospho-
pantetheinylation Assay. Temperature and pH optima, along
with PPTase reaction time, were determined. In addition, the
effect of protease inhibitors (phenylmethylsulfonyl fluoride;
Table 2. Reagent Preparation for Solid Phase
4′-Phosphopantetheinylation Assaya
reagent stock
solutions
purified
PPTase
PPTase crude
cell lysate
control cell
lysate
biotin CoA
control
buffer
control
purified PPTase
(0.5 µM)
95 µL - - - -
PPTase lysate
(1.7 mg/mL total
cell protein)
- 30 µL - - -
control lysate
(1.7 mg/mL total
cell protein)
- - 30 µL - -
biotin-CoA (109 µm) 5 µL 5 µL 5 µL 5 µL -
Ppant buffer - 55 µL 55 µL 95 µL 100 µL
a Final reagent concentrations: Biotin-CoA (5.4 µM), PPTase purified
from infected Sf9 cell supernatants (0.48 µM), PPTase cell lysate
obtained from infected Sf9 insect cells (0.51 mg/mL total cell protein),
and as a control, cell lysate obtained from un-infected Sf9 insect cells
(0.51 mg/mL total cell protein).
Table 3. Reagent Preparation for Solid Phase
4′-Phosphopantetheinylation Assay (B)a
reagents purifiedPPTase
PPTase crude
cell lysate
control cell
lysate
Fl-CoA
control
buffer
control
purified PPTase
(0.5 µM)
95 µL
PPTase lysate
(1.7 mg/mL total
cell protein)
- 30 µL - - -
control lysate
(1.7 mg/mL total
cell protein)
- - 30 µL - -
Fl-CoA (95 µM) 5 µL 5 µL 5 µL 5 µL -
Ppant buffer - 60 µL 60 µL 90 µL 100 µL
a Final reagent concentrations; Fl-CoA (3.6 µM), PPTase purified
from infected Sf9 cell supernatants (0.48 µM), PPTase cell lysate
obtained from infected Sf9 insect cells (0.51 mg/mL total cell protein),
and as a control, cell lysate obtained from un-infected Sf9 insect cells
(0.51 mg/mL total cell protein).
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PMSF) inclusion on PPTase cell lysate stability was investigated.
Student’s t test was used to assess the statistical significance of
relevant results. Absorbance values for control lysate (lacking
PPTase) were subtracted from PPTase lysates for calculation
of relative PPTase activity (%). The mean absorbance value
for purified PPTase was set at 100% with all other values
(PPTase lysate and biotin-CoA controls) expressed as a percent-
age of this.
RESULTS
Recombinant Protein Expression, Purification, and Solu-
bilization. Pes3AT was found to be highly insoluble under
nondenaturing conditions (data not shown) and was solubilized
by addition of 6 M guanidine-HCl containing 1 mM DTT to
a final concentration of 30 mg/mL or 5 mg/g cells. SDS-PAGE
analysis and Western blot analysis confirmed the required purity
of Pes3AT (Figure 2). The 72 kDa Pes3AT band observed on the
Coomassie stained gel was excised and subjected to MALDI-
ToF mass spectrometry. Resultant tryptic digest peptide monoiso-
topic m/z values (Table 4), compared to those of an in silico
digest of Pes3AT, represented 20% sequence coverage thereby
providing conclusive confirmation of Pes3AT identity. Pes3AT
was solubilized under nondenaturing conditions by dilution into
Ppant buffer containing 8 M urea (4 mL) at 0.5 mg/mL Pes3AT
followed by serial dialysis into Ppant buffer (final concentration:
0.41 mg/mL (5.75 µM)). This solubilized Pes3AT preparation
was aliquoted and stored at -20 °C for subsequent use. The 36
kDa T-GstB fusion protein was purified from E. coli cell lysates
resulting in a T-GstB yield of 13 mg/mL or 5 mg/g cells (Figure
2).
Following infection with recombinant baculovirus encoding
A. fumigatus PPTase, Spodoptera frugiperda insect cell lysates
were prepared by sonication in the presence of 0.05% (w/v)
sodium deoxycholate in Ppant diluent. Purified PPTase was
obtained by incubation with Ni-NTA affinity resin for 2 h
followed by elution with 250 mM imidazole and dialysis into
Ppant diluent (yield: 0.33 mg/108 cells) (Figure 3).
Labeled CoA Conjugate Synthesis. Biotin-CoA conjugates
were prepared by reacting MB with CoA to form a stable
thioether-mediated conjugate for subsequent assay development.
Prior to addition of free DTT to scavange any unreacted MB,
a new method was deployed to determine the efficiency of
biotin-CoA conjugate formation, which involved determination
of residual CoA using aldrithiol-4 (4,4′-dithiodipyridine) reagent
(Supplementary information). This analysis confirmed ef-
Figure 2. Purification of recombinant Pes3AT and T-GstB by differential
extraction. (A) Coomassie stained SDS-PAGE gel of Pes3AT fractions
obtained from crude extraction method. Lane M, molecular mass
marker; lane 1, unpurified Pes3AT; lane 2, cell lysate; lanes 3-5: Triton
X-100 washes; lane 6, 2 M urea wash; lane 7, 8 M urea wash; lane 8,
purified Pes3AT in 6 M guanidine-HCl. (B) Western blot analysis of
Pes3AT. Lane M, molecular mass marker; lane 1, unpurified Pes3AT;
lane 2, Pes3AT purified by differential extraction method. Western blot
analysis was carried out using 1/1000 dilution of anti-His6 monoclonal
antibody and 1/1000 dilution of anti-mouse IgG-HRP conjugate. (C)
SDS-PAGE analysis of T-GstB fractions obtained from crude extraction
method. Lane M, molecular mass marker; lane 1, unpurified T-GstB
lysate; lane 2, wash fraction; lane 3, 8 M urea wash (20 µg); lane 4, 8
M urea wash (2 µg). (D) Western blot analysis of purified T-GstB.
Lane M, molecular mass marker; lane 1, T-GstB lysate; lane 2, wash
fraction; lanes 3 and 4, 8 M urea wash (0.5 and 1 µg/track, respectively)
T-GstB.
Table 4. Peptides Identified Following Trypsin Digestion of
Recombinant Pes3AT and MALDI-ToF Mass Spectrometry Analysisa
m/z (Da) identified peptides
900.39 R Y A D W M A K Y L M V K R
1656.85 K K S V W T M V A M L A I M K
1590.88 K R I L D D T E A P L V I V H R
1523.84 K G I V V P H R S I A T S M R
1930.95 R W N D L A G A M E R L G V N W A K
1288.737 R L L H P E Q V P S L R
1674.8 R Q V G G T L H V V D A G N H D R
1273.61 H R D E D G V L Y H L L G R
1531.66 K V A E H S T D T S AD N E R
a The peptides identified represent 20% coverage of the Pes3AT and
confirm the identity of the protein.
Figure 3. Purification of intracellular PPTase from Sf9 cell lysate. (A)
SDS-PAGE and (B) Western blot analysis of PPTase purification using
anti-His6 monoclonal antibody and 1/1000 dilution of anti-mouse IgG-
HRP conjugate. Lane 1, molecular mass markers; lane 2, control PPTase
cell lysate; lane 3, PPTase cell lysate 1; lanes 4-6, unbound; lane 7:
Ni-NTA affinity column eluate containing purified PPTase.
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fectively 90%+ efficiency of biotin-CoA conjugate synthesis
and extends the utility of aldrithiol-4 and other reagents used
for thiol group determination (18). Previously, identical biotin-
CoA analogues were synthesized, the unincorporated biotin
reporter extracted via the use of scavenger resins, and the
resultant biotin-CoA reporter subsequently used for the high-
sensitivity detection (100 pg) of the biotin labeled recombinant
VibB carrier protein domain (6). However, we observed minimal
background protein modification once DTT was added to biotin-
CoA conjugates, which implies that removal of unreacted MB
may not always be necessary. A fluorescently linked CoA
analogue was also synthesized using 5′-iodoacetamidofluores-
cein (5′-IAF), which alkylates the sulfhydryl group of CoA.
Fluorescent detection offers the potential advantage of direct
analysis of labeled proteins without the need for enzyme
conjugates and chemiluminescent substrates (19). The produc-
tion of fluorescein-CoA was confirmed by TLC analysis;
however, evidence of unreacted 5′-IAF in the fluorescein-CoA
sample was also observed (data not shown). As with biotin-
CoA conjugates, it was found that subsequent addition of DTT
eliminated nonspecific fluorescent labeling of target proteins.
In addition, RP-HPLC analysis was also used to detect the
production of fluorescein-CoA conjugates with the appearance
of a new peak with a lower retention time of 17.0 min for the
fluorescein-CoA test specimens which is likely due to the higher
polarity of Fl-CoA molecule compared to 5′-IAF (data not
shown).
4′-Phosphopantetheinylation of Pes3AT with Biotin- and
Fluorescein-CoA is Mediated by PPTase. Pes3AT was subject
to specific 4′-phosphopantetheinylation by PPTase present in
insect cell lysates (Figure 4a). Here, modification of the Pes3AT
(4.4 µM) was clearly detectable using PPTase-containing insect
cell lysates (17-1700 µg/mL total protein), with a weak signal,
corresponding to specific 4′-phosphopantetheinylation, at 3 µg/
mL total cell protein. No 4′-phosphopantetheinylation was
detectable in the presence of control insect cell lysate, thereby
providing confirmation that modification of Pes3AT with biotin-
CoA was mediated specifically by PPTase and not as a result
of direct nonspecific labeling of Pes3AT with residual MB.
Omission of Pes3AT from the reaction likewise produced a
negative result, which confirmed that proteins in the insect cell
lysate were not labeled nonspecifically with biotin-CoA (Figure
4a). Replacement of biotin-CoA with fluorescein-CoA as the
PPTase substrate also facilitated post-translational modification
of Pes3AT (Figure 4b). Here, Pes3AT (4.44 µM) was labeled using
both purified PPTase (0.08 µM) and PPTase present in insect
cell lysate (34 µg/mL total cell protein). No 4′-phosphopan-
tetheinylation was detectable in the absence of either PPTase
or Pes3AT. Overall, these observations confirm that the Pes3AT
thiolation domain can be post-translationally modified by
PPTase with either biotinylated or fluorescently labeled CoA.
High-Throughput Detection of 4′-Phosphopantetheinyla-
tion. Reaction mixtures containing combinations of purified
PPTase, Pes3AT, and fluorescein-CoA were incubated in solution
for 1 h and subsequently transferred to black microtiter plates,
Figure 4. Chemoenzymatic labeling of Pes3AT. (A) Western blot showing 4′-phosphopantetheinylation of Pes3AT using a range of PPTase-containing
Sf9 cell lysates. Final concentrations of Pes3AT (4.4 µM) and biotin CoA (8.4 µM) were used. Western blots were probed with streptavidin-HRP
and developed with ECL substrate. Lanes 1-7, 1.7-0.003 mg/mL, total cell protein; lane 8, Pes3AT negative control; lane 9, Cell lysate negative
control. Results shown are representative of duplicate analysis. (B) SDS-PAGE analysis of 4′-phosphopantetheinylation of Pes3AT by PPTase using
fluorescein-CoA. (i) Fluorescent analysis was carried out on the Typhoon scanner (Amersham). Lane M, protein marker; lanes 1 and 2, PPTase-
containing cell lysate; lanes 3 and 4, purified PPTase (0.08 µM); lanes 5 and 6, PPTase negative control; lane 7, Fl-CoA negative control; lane 8,
Pes3AT negative control. (ii) Coomassie staining of the above SDS-PAGE gel showing identical Pes3AT loading (lanes 1-7).
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incubated for a further 1 h, followed by washing with PBST
(2×) to remove unbound fluorescein-CoA. Fluorescent analysis
at 490/520 nm (ex/em) (Figure 5) indicated that fluorescently
labeled Pes3AT had bound to the plate and was detectable by
fluorescence analysis. Fluorescence labeling was predominantly
mediated by PPTase modification; however, nonspecific labeling
was also evident (up to 25%) in the absence of PPTase. No
fluorescence was detectable in the absence of Pes3AT.
For technical reasons, direct detection of biotinylated Pes3AT
on microwells was not possible as described for fluorescent
Pes3AT above (data not shown). However, 4′-phosphopanteth-
einylation was possible using microwells precoated with Pes3AT
(4.4 pmol), and stabilized by BSA addition (Figure 6a). To
ensure that biotin labeling of the bound Pes3AT protein was the
result of PPTase activity and not due to the presence of insect
cell proteins present in the crude cell lysate, control reactions
were included whereby uninfected insect cell lysates (at identical
total protein concentration) were incubated in the Pes3AT coated
microwells in the presence of biotin-CoA, and resultant absor-
bance values compared to those obtained from incubation with
PPTase insect cell lysate. Background activity was apparent in
uninfected cell lysate controls compared to the biotin-CoA and
Ppant buffer controls, but these absorbance values were only
16-25% of those obtained for the wells incubated with PPTase
insect cell lysate (mean A450/630 nm: 1.7), thereby confirming that
labeling of Pes3AT was due to PPTase present in the insect cell
lysate. Consequently, PPTase cell lysate was used for subsequent
analysis of PPTase activity using this assay format (Figure 6b).
Control insect cell lysate (uninfected cells) was also included
in subsequent analysis, and absorbance values obtained for these
samples subtracted from the PPTase cell lysate specimens to
correct for any nonspecific labeling that may be a result of native
insect cell proteins. PPTase-mediated fluorescein-CoA modifica-
tion of immobilized Pes3AT has also been demonstrated (Figure
6c). Here, nonspecific modification (approximately 25% of the
PPTase reaction) was also evident.
Purified PPTase from insect cells lysates also functions in
the solid phase 4′-phosphopantetheinylation reaction (Figure 6d).
No significant difference was observed between purified PPTase
and PPTase cell lysate (at an equivalent dilution; P ) 0.56),
whereas significantly greater 4′-phosphopantetheinylaiton activ-
ity was evident compared to biotin-CoA only negative control
(P ) 0.00036).
Fungal Thiolation Domain Facilitates Labeling of Non-
Native Substrate Proteins. T-GstB was post-translationally
modified by 4′-phosphopantetheinylation with biotinylated 4′-
phosphopantetheine when immobilized in microwells (Figure
7). Moreover, background signal arising from GstB negative
control was less than 5% of overall T-GstB signal, demonstrating
conclusively that the discrete thiolation domain of T-GstB was
specifically modified by PPTase activity, even when fused to a
non-native protein (i.e., GstB).
Characterization of PPTase Activity. Following the estab-
lishment of the in Vitro 4′-phosphopantetheinylation assay in a
solid phase (96 well plate) format using biotin-CoA and PPTase
insect cell lysates, temperature, pH optima, and reaction time-
course were investigated. Analysis of these data revealed that
optimal PPTase activity was evident at 24 °C, with reduced
4′-phosphopantetheinylation observed at 4, 37, and 50 °C
(Figure 8a). A statistically significant higher PPTase activity
was observed when protease inhibitors were included in the
insect cell lysates. This result implies that, in the absence of
protease inhibitors, proteases present in the crude insect cell
lysate may degrade PPTase and therefore lower the extent of
post-translational modification (Figure 8a). The overall affect
of pH on PPTase activity is shown in Figure 8b whereby
background absorbance values obtained from the insect cell
lysate control samples were subtracted from the absorbance
values obtained from PPTase lysate reactions. From this
analysis, it is clear that pH has an effect on the activity of
PPTase with optimal 4′-phosphopantetheinylation occurring at
pH 8.0. 4′-Phosphopantetheinylation is 75% complete within
1 h, and complete protein labeling is achieved after 3 h reaction
(Figure 8c).
DISCUSSION
Despite recent advances in PPTase-mediated labeling of
T/PCP or ACP domains of prokaryotic origin, via biotinylated
or fluorescently modified CoA analogues, minimal information
on this approach for eukaryotic (fungal) T domain modification
is available. Moreover, facile determination of PPTase activity
has remained a challenge. Here, data are presented which
confirm that T domains of fungal origin can be post-transla-
tionally modified, both in solution and when immobilized on a
solid surface, using a combination of modified CoA analogues
and a functional PPTase. We also demonstrate that T domains
can be transferred to a non-native protein (GstB) and that this
fusion protein (T-GstB) is also a substrate for PPTase-mediated
modification. Finally, it appears that the solid phase assay format
presents a new strategy for determination of PPTase activity
which is faster than current methods and is compatible with
high-throughput functionality.
The gene encoding Pes3 represents the largest NRPS open
reading frame in the A. fumigatus genome. Here, we have
expressed the first AT didomain of Pes3 and a T-GstB fusion
protein, in E. coli at high yields (5 mg/g cells). We have
previously cloned and expressed recombinant PPTase in the
baculovirus expression system, purified from PBS washes of
intact cells by subsequent Ni-NTA chromatography, and shown
it to be capable of transferring the Ppant group from CoA to
the T domain derived from a distinct A. fumigatus NRPS (pes1)
(2). However, in the present work we utilize PPTase, of
intracellular origin, which was extracted in high yields (3.33
mg/109 cells) and purified by Ni-NTA affinity chromatography.
Interestingly, PPTase activity was detectable in crude cell
lysates, indicating that enzyme purification is not always
essential.
Figure 5. Solid phase 4′-phosphopantetheinylation assay using Fl-CoA.
After solution phase incubation, 4′-phosphopantetheinylation reactions
(and appropriate controls) were coated on black microtiter plates and
subsequently analyzed by fluorescence with excitation and emission at
490 and 520 nm, respectively. Results given represent the mean ((SE)
of the experiment performed in triplicate. All reaction constituents:
Pes3AT; PPTase; Fl-CoA. PPTase negative control: PPTase absent from
reactions. Ppant buffer control: Ppant buffer only. Ppant buffer and
fluorescein-CoA (Fl-CoA) only: Pes3AT and PPTase absent from
reactions.
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To confirm reagent functionality, recombinant Pes3AT was
subjected to solution phase biotin- and fluorescein-CoA labeling,
respectively, in the presence and absence of PPTase followed
by chemiluminescent or direct fluorescence detection (Figure
4). Significantly, Pes3AT (4.4 µM) labeling was observed in all
cases in the presence of either purified PPTase or insect cell
lysates, which contained impure, but active, preparations of the
enzyme. To our knowledge, this is the first demonstration that
fungal T domains can be chemoenzymatically labeled with CoA
analogues, that crude PPTase preparations can be used to effect
in Vitro 4′-phosphopantetheinylation, and also that the enzyme
produced within recombinant baculovirus-infected insect cells is
active. Detection of fluorescein-labeled Pes3AT (4.4 µM) was
achieved using 7.3 µM fluorescein-CoA and using either 0.08 µM
purified PPTase and crude PPTase cell lysate at a concentration
of 0.034 mg/mL (estimated to contain 0.92 µM PPTase). Thus,
the molar ratios of purified PPTase, carrier protein, and fluorescein-
CoA used were approximately 1:55:90. The PPTase mediated
modification of the Pyochelin NRP synthetase carrier proteins
PchE and PchF using similar fluorescein-CoA analogues has
been reported (13). The in Vitro 4′ phosphopantetheinylation
assays used in that study, however, used 2 µM B. subtilis Sfp,
300 µM fluorescein-CoA, and PchE/PchF carrier proteins at
concentrations of 10 and 21 µM, respectively. The molar ratios
of PPTase, carrier protein, and fluorescein-CoA in the present
study were 1:5-10:150, respectively, similar to fluorescein-
CoA-PPTase assay described herein; however, the assay of ref
13 required approximately 5-fold more carrier protein and 25
times more PPTase (Sfp), respectively.
In order to eliminate the time-consuming electrophoretic step
associated with labeled carrier protein detection and expedite
analysis, we attempted direct immobilization of reaction mix-
tures to microwells, subsequent to in Vitro 4′-phosphopanteth-
einylation followed by visualization and absorbance detection.
This approach was unsuitable for use with biotin-CoA reporter
analogues as the biotin moiety exhibited high nonspecific
binding to microwells thereby masking any possibility of
detecting PPTase mediated Pes3AT labeling (data not shown).
However, the approach was successfully applied to in Vitro 4′-
phosphopantetheinylation assays using a fluorescein-labeled
CoA analogue whereby 3-fold greater fluorescence was detect-
able in specimens containing PPTase, Fl-CoA and Pes3AT
compared to specimens containing Fl-CoA and Pes3AT alone
(Figure 5). Although extensive validation of this approach has
Figure 6. (A) Diagrammatic representation of solid phase 4′-phospho-
pantetheinylation. Immobilized thiolation domains (e.g., in Pes3AT)
(green circles) are stabilized by the addition of BSA (dashed line). The
reactive serine residue (-OH) on the thiolation domain can then be
modified with biotin-CoA in the presence of PPTase. PPTase activity
is then indirectly detected by addition of streptavidin-HRP conjugate
and TMB substrate. Fluorescein-CoA (Fl-CoA) can be substituted for
biotin-CoA followed by subsequent direct fluorescent detection of the
labeled thiolation domain. (B) Solid phase 4′-phosphopantetheinylation
assay using biotin-CoA. In Vitro 4′-phosphopantetheinylation assays
were carried out on plates coated with Pes3AT (2 µg/mL). Results given
represent the mean ((SE) of the experiment performed in triplicate.
(C) Solid phase 4′-phosphopantetheinylation assay using fluorescein-
CoA. 4′-Phosphopantetheinylation assays were performed in microwells
coated with Pes3AT (2 µg/mL). Results given represent the mean ((SE)
of the experiment performed in triplicate. (D) Solid phase 4′-
phosphopantetheinylation of Pes3AT using purified PPTase (29 µg; 0.7
nmol) and PPTase cell lysate. Results given represent the mean ((SE)
of the experiment carried out in triplicate.
Figure 7. Solid phase 4′-phosphopantetheinylation of T-GstB. Net post-
translational modification activity in PPTase cell lysate, toward for
T-GstB and GstB, respectively, was calculated by subtracting back-
ground signals in control insect cell lysate. Results given represent the
mean ((SE) of three individual experiments. Students t test was used
to calculate P-values for the difference between the T-GstB and the
GstB (P ) 0.0003).
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not been undertaken, we propose that this hybrid assay format,
involving solution phase, in Vitro phosphopantetheinylation and
reaction product immobilization for fluorescent detection, may
find future application.
A number of groups have confirmed that proteins fused to
either T domains of bacterial origin, or peptides derived from
phage display, can be covalently tethered to immobilized CoA,
and this observation has been proposed as a new strategy for
protein array preparation (9, 20). However, to date, labeled
pantetheine transfer to immobilized T domains, in either native
or non-native configuration, has not been demonstrated. The
75 amino acid T domain used in our study is equivalent in size
to other fungal and bacterial T domains but considerably longer
than ybbR-like tags introduced by other groups (8). The use of
the T domain of fungal (A. fumigatus) origin as a target for
C-terminal labeling of Pes3AT and N-terminal labeling of
T-GstB, respectively, suggests that domain acceptor function
is independent of position in the substrate protein. We have
observed that purified Pes3AT or T-GstB can be stably and
irreversibly attached to microwells, blocked to minimize
nonspecific binding, and followed by PPTase-mediated bioti-
nylation or fluorescent labeling using either biotin-CoA or
fluorescein-CoA. This finding represents a new strategy for
assessment of both T domain functionality and PPTase activity
determination and potentially for the assessment of PPTase/
AcpS/Sfp inhibitors, which have been proposed as potential drug
targets (14).
Our data indicate that 0.33 µg (4.4 pmol) Pes3AT can be
detected using 29 µg (0.7 nmol) of recombinant PPTase (in
either purified or crude form) in the presence of biotin-CoA
via solid phase phosphopantetheinylation. It also suggests that
any conformational restriction due to Pes3AT immobilization
does not significantly impede phosphopantetheinylation. More-
over, chemoenzymatic detection is statistically significant (P <
0.05) over protein labeling in the absence of recombinant
PPTase. Importantly, we also demonstrate that the T domain
derived from Pes3AT can be fused to an unrelated protein and
also be subjected to solid phase phosphopantetheinylation. This
confirms the discrete functionality of the T domain and strongly
suggests that they can be used as a fusion partners for unrelated
proteins to facilitate targeted labeling procedures.
In order to optimise the in Vitro 4′-phosphopantetheinylation
assay and to further characterize PPTase activity, assays were
performed at different reaction temperatures. Initial in Vitro 4′-
phosphopantetheinylation assays using the A. fumigatus encoded
recombinant PPTase (2) were carried out at a reaction temper-
ature of 37 °C; however, optimal PPTase activity occurs at 25
°C with 100% increase in the extent of Pes3AT modification
observed compared to that at 37 °C. In Vitro 4′-phosphopan-
tetheinylation assays employing the use of the B. subtilis PPTase
Sfp, were carried out at room temperature and 30 °C,
respectively (6, 13). Furthermore, the in Vitro phosphopanteth-
einylation assays used to assess the affect of PPTase (AcpS)
specific inhibitors on the ability of the B. subtilis AcpS to post-
translationally modify the ACP carrier protein were also
performed at 25 °C (14).
Subsequent to determination of optimal PPTase reaction
temperature, the effect of pH on PPTase activity was also
investigated and revealed that optimal PPTase activity was
observed at pH 8.0 (100%), with a significant decrease in
PPTase activity to 45%, 65%, and 35% for pH 4.0, pH 6.5,
and pH 10.0, respectively. These observations are in accordance
with those for the in Vitro phosphopantetheinylation assays used
for B. subtilis AcpS type PPTase, which were also carried out
at pH 8.0 (14). However, a clear pH optimum at pH 6.0 for the
B. subtilis Sfp type PPTase, with activity reducing to less than
20% of the optimum pH for pH 5.0 and pH 7.0, respectively,
has been reported (3). Thus, it is clear that optimal reaction
conditions should be established for each specific PPTase or
equivalent AcpS/Sfp enzyme.
Figure 8. (A) The effect of temperature on PPTase activity in the
presence and absence of protease inhibitors. Results given represent
the mean ((SE) of three individual experiments. Student’s t test was
used to calculate P-values for the difference between the control (24
°C + protease inhibitors) and the following conditions: 4 °C (+/-
protease inhibitors (P ) 0.003; P ) 0.0009)), 24 °C (- protease
inhibitors (P ) 0.03)), 37 °C (+/- protease inhibitors (P ) 0.005; P
) 0.0002)), and 50 °C (( protease inhibitors (P ) 0.00001; P )
0.00002)). (B) The effect of pH on PPTase activity. Results are
expressed as percent (%) relative to the highest level, i.e., pH 8.0, and
represent the mean ((SE) of three individual experiments. Student’s t
test was used to calculate P-values for the difference between the control
(pH 8.0) and the following pH conditions: 4.0 (P ) 0.01), 6.5 (P )
0.008), and 10.0 (P ) 0.0003). (C) The effect of reaction time on
PPTase activity. Optimal reaction time is 2 h; however, PPTase-
mediated protein modification is up to 75% complete by 1 h.
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In summary, we have demonstrated that solid phase in Vitro
4′-phosphopantetheinylation, using either biotin- or fluorescein-
CoA substrate analogues, of fungal thiolation domains in native
or non-native configuration is possible. Moreover, we have
conclusively shown that the solid phase assay format presents
a new strategy for determination of PPTase activity, which is
superior to current approaches and highly likely to be compatible
with high-throughput screening systems for PPTase inhibitor
identification. We also suggest that solid phase 4′-phosphopan-
tetheinylation may be compatible with the ongoing search for
peptide mimotopes, in part via phage display, of T domain
functionality (21, 22).
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